Brechbiel MW - Search Results

1

Evaluation of copper chelation agents as anti-angiogenic therapy.

Camphausen K, Sproull M, Tantama S, Sankineni S, Scott T, Ménard C, Coleman CN, Brechbiel MW. Camphausen K, et al. Among authors: brechbiel mw. Bioorg Med Chem. 2003 Sep 15;11(19):4287-93. doi: 10.1016/s0968-0896(03)00401-2. Bioorg Med Chem. 2003. PMID: 12951159

2

Antiangiogenic therapy through copper chelation.

Sproull M, Brechbiel M, Camphausen K. Sproull M, et al. Expert Opin Ther Targets. 2003 Jun;7(3):405-9. doi: 10.1517/14728222.7.3.405. Expert Opin Ther Targets. 2003. PMID: 12783576 Review.

3

Evaluation of chelating agents as anti-angiogenic therapy through copper chelation.

Camphausen K, Sproull M, Tantama S, Venditto V, Sankineni S, Scott T, Brechbiel MW. Camphausen K, et al. Among authors: brechbiel mw. Bioorg Med Chem. 2004 Oct 1;12(19):5133-40. doi: 10.1016/j.bmc.2004.07.034. Bioorg Med Chem. 2004. PMID: 15351396

4

N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation.

Regino CA, Torti SV, Ma R, Yap GP, Kreisel KA, Torti FM, Planalp RP, Brechbiel MW. Regino CA, et al. Among authors: brechbiel mw. J Med Chem. 2005 Dec 15;48(25):7993-9. doi: 10.1021/jm050724r. J Med Chem. 2005. PMID: 16335923 Free PMC article.

5

Synthesis and potent antitumor activities of novel 1,3,5-cis,cis-triaminocyclohexane N-pyridyl derivatives.

Chong HS, Torti SV, Ma R, Torti FM, Brechbiel MW. Chong HS, et al. Among authors: brechbiel mw. J Med Chem. 2004 Oct 7;47(21):5230-4. doi: 10.1021/jm040076w. J Med Chem. 2004. PMID: 15456266

6

Preliminary evaluation of the cytotoxicity of a series of tris-2-aminoethylamine (Tren) based hexadentate heterocyclic donor agents.

Torti SV, Ma R, Venditto VJ, Torti FM, Planalp RP, Brechbiel MW. Torti SV, et al. Among authors: brechbiel mw. Bioorg Med Chem. 2005 Nov 1;13(21):5961-7. doi: 10.1016/j.bmc.2005.07.007. Bioorg Med Chem. 2005. PMID: 16115775

7

Novel chelating agents for potential clinical applications of copper.

Ma D, Lu F, Overstreet T, Milenic DE, Brechbiel MW. Ma D, et al. Among authors: brechbiel mw. Nucl Med Biol. 2002 Jan;29(1):91-105. doi: 10.1016/s0969-8051(01)00287-6. Nucl Med Biol. 2002. PMID: 11786280 Review.

8

National Cancer Institute support for targeted alpha-emitter therapy.

Hong JA, Brechbiel M, Buchsbaum J, Canaria CA, Coleman CN, Escorcia FE, Espey M, Kunos C, Lin F, Narayanan D, Capala J. Hong JA, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):64-72. doi: 10.1007/s00259-021-05503-z. Epub 2021 Aug 11. Eur J Nucl Med Mol Imaging. 2021. PMID: 34378064 Review.

9

Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA.

Wu C, Kobayashi H, Sun B, Yoo TM, Paik CH, Gansow OA, Carrasquillo JA, Pastan I, Brechbiel MW. Wu C, et al. Among authors: brechbiel mw. Bioorg Med Chem. 1997 Oct;5(10):1925-34. doi: 10.1016/s0968-0896(97)00130-2. Bioorg Med Chem. 1997. PMID: 9370037

10

Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.

Chong HS, Garmestani K, Ma D, Milenic DE, Overstreet T, Brechbiel MW. Chong HS, et al. Among authors: brechbiel mw. J Med Chem. 2002 Aug 1;45(16):3458-64. doi: 10.1021/jm0200759. J Med Chem. 2002. PMID: 12139456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters